DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
Several technologies for hemoglobinopathies are being transferred to commercial partners
India currently hosts more than 10,075 biotech startups
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Subscribe To Our Newsletter & Stay Updated
